ated in COPD lung (2, 47) , indicating that cellular senescence may be fundamentally involved in the pathogenesis of COPD. Furthermore, cigarette smoke (CS) exposure, a known main cause of COPD (12) , has been widely demonstrated to accelerate cellular senescence (15, 19, 48) .
Although the precise mechanisms of cellular senescence are still obscure, "the free radical theory of aging" has thus far been widely accepted (20) . This theory proposes that accumulation of damaged macromolecules caused by reactive oxygen species (ROS) induces functional deterioration, resulting in cellular senescence. Indeed, protein and lipid oxidation increase with age (23, 31, 36) , and ROS (11) and oxidative stress-induced lipid and protein modifications (17, 19, 40) have been demonstrated to be increased in COPD lung, suggesting that ROS may play an important role in the pathogenesis of COPD through the acceleration of cellular senescence.
Mitochondria are not only important organelles for ATP production but also the main site for ROS release through respiratory chain reactions (25) . Hence, mitochondrial dysfunction has been shown to be responsible for cellular senescence (35, 42) . Mitochondria are highly dynamic organelles that constantly fuse and divide (42, 54) , and growing evidence suggests that the balance between fusion and fission is critical for determination of not only cellular function but also cell fate through the regulation of mitochondrial ROS production (43, 55) . Indeed, mitochondrial dynamics have been demonstrated to play crucial roles in the pathogenesis of neurodegenerative disorders, including Parkinson's disease (41) , diabetes mellitus (43) , and heart failure (10) . However, the involvement of mitochondrial dynamics in lung diseases has not been studied extensively.
Although several lines of evidence demonstrated that CS exposure induces mitochondrial respiratory chain dysfunction and enhances mitochondrial ROS production in lung epithelial cells (50, 51) , the participation of mitochondrial dynamics in CS-induced mitochondrial deterioration in the context of COPD pathogenesis has not been examined. Hence, we explored the involvement of mitochondrial dynamics in mitochondrial integrity, ROS production, and regulation of cellular senescence in the setting of cigarette smoke extract (CSE) exposure.
MATERIALS AND METHODS
Cell culture. Normal airways were obtained from first-through fourth-order bronchi from pneumonectomy and lobectomy specimens for primary lung cancer. Informed consent was obtained from all surgical participants as part of an approved ongoing research protocol by the ethical committee of Jikei University School of Medicine. Human bronchial epithelial cells (HBEC) were isolated with protease treatment and characterized as previously described (15, 19) . Briefly, airways were treated with protease overnight, and cells derived from the airways were collected and plated on rat tail collagen type I-coated (10 g/ml) dishes. After incubation overnight, the medium was changed to bronchial epithelial growth medium (Clonetics, San Diego, CA). Cultures were characterized immunohistochemically using antivimentin (Sigma-Aldrich, St. Louis, MO) and anticytokeratin (Lu-5; BioCare Medical, Concord, CA) antibodies. HBEC showed Ͼ95% positive staining with anticytokeratin and Ͻ5% positive staining with the antivimentin antibody.
Antibodies and reagents. Mouse monoclonal antibodies for Mitofusin1 (Abcam, Cambridge, MA), Mitofusin2 (Abcam), Drp1 (Cell Signaling Technology, Beverly, MA), ␤-actin (Sigma-Aldrich), TOM20 (Santa Cruz Biotechnology, Santa Cruz, CA), SDHA (Abcam), and HSP90 (BD Biosciences, San Jose, CA) and rabbit polyclonal antibodies for p21 (Cell Signaling Technology), OPA1 (Novus Biologicals, Littleton, CO), and Fis1 (Santa Cruz) were used. CM-H 2 DCFDA, bisbenzimide H 33258, and rat tail type-I collagen were purchased from Sigma-Aldrich. MitoTracker Red CMXRos and Mito SOX Red were purchased from Life Technologies (Carlsbad, CA). N-acetylcysteine (NAC) and hydrogen peroxide (H 2O2) were obtained from Wako (Osaka, Japan). Mito-TEMPO-H was purchased from Enzo Life Sciences (Farmingdale, NY).
Mitochondria isolation. Mitochondria fractions are isolated from HBECs by a commercially available kit (Thermo Scientific, Waltham, MA) according to the manufacturer's instructions.
Preparation of CSE. CSE solution was prepared as described previously with some modifications (15, 19) . Briefly, 10 ml of CS were drawn into a syringe and passed through 10 ml of PBS in a 15-ml Falcon tube. The smoke was expelled, and the process was repeated until one cigarette was used up. CSE solution was filtered (0.22 m). The resulting solution was designated a 100% CSE solution and was used with the indicated dilution in the cell culture medium.
Senescence-associated ␤-galactosidase staining. Senescence-associated ␤-galactosidase (SA-␤-gal) staining was performed using HBEC grown on 24-well culture plates according to the manufacturer's instructions (␤-galactosidase staining kit; BioVision Research Products).
Electron microscopy. Lung tissues from pneumonectomy and lobectomy specimens were fixed with 2% glutaraldehyde/0.1 M phosphate buffer (PB) (pH 7.4) and in 1% osmium tetroxide/0.1 M PB (pH 7.4) and dehydrated with a graded series of ethanol. Fixed tissues were then embedded in epoxy resin. Ultrathin sections were stained with uranyl acetate and lead citrate and observed with the Hitachi H-7500 transmission electron microscope (Hitachi, Tokyo, Japan).
Immunocytochemistry. Immunocytochemical staining was performed as previously described (15, 18) . HBEC grown on eight-well culture plates were fixed with 4% paraformaldehyde for 15 min followed by permeabilization with 0.03% Triton X for 60 min. After being blocked with 0.1% BSA for 60 min, the primary and secondary antibodies were applied according to the manufacturer's instructions. Fluorescence microscopic analysis of mitochondrial morphology was performed by TOM20 staining. Concomitant staining with MitoTracker Red (200 nM, 30 min at 37°C) was also performed to evaluate integrity of membrane potential. Mitochondrial morphology was classified into the following three groups based on staining pattern (staining present in Ͼ80% of all mitochondria) (Fig. 1B) : elongated, tubular mitochondria longer than 5 m partially with network formation; fragmented, mitochondria shorter than 1 m without fusion to other mitochondria (usually round shape); others, staining pattern other than former two types.
Mitochondrial superoxide generation. Mitochondrial superoxide production was evaluated by Mito SOX Red (a fluorogenic dye for the highly selective detection of superoxide in the mitochondria) according to the manufacturer's instructions. Mito SOX Red staining was evaluated by fluorescence microscopy and by flow cytometric analysis with a MACSQuant Analyzer (Miltenyi Biotec, Bergisch Gladbach, Germany).
Measurement of ROS production in total cells. CM-H 2 DCFDA (Invitrogen) was used to measure total cellular ROS according to the manufacturer's instructions. After incubation with CM-H 2 DCFDA (10 M) for 10 min at 37°C, cells were harvested and immediately evaluated by MACSQuant Analyzer.
Western blotting. HBEC grown on six-well culture plates were lysed in RIPA buffer (Thermo Fisher Scientific) with protease inhibitor cocktail (Roche Diagnostics, Basel, Switzerland) and 1 mM sodium orthovanadate. Western blotting was performed as previously described (15, 19) . For each experiment, equal amounts of total protein were resolved by 10 -15% SDS-PAGE. After SDS-PAGE, proteins were transferred to a polyvinylidene difluoride membrane (Immobilon-P; Millipore), and incubation with specific primary antibody was performed for 1 h at room temperature. After being washed several times with PBST, the membrane was incubated in horseradish peroxidase-conjugated secondary antibody (Bethyl Laboratories) followed by chemiluminescence detection with a kit (SuperSignal West Pico Chemiluminescent Substrate; Thermo Fisher Scientific) with the LAS-4000 UVmini system (Fujifilm, Tokyo, Japan).
Small-interfering RNA transfection. Small-interfering RNA (siRNA) targeting MFN1, MFN2, OPA1, Fis1, Drp1, and negative control siRNAs were purchased from Life Technologies. Transfections of HBEC were performed using the Neon transfection system (Invitrogen), using matched optimized transfection kits for airway epithelial cells.
The sequences of siRNA are as follows: siRNA against MFN1 was 5=-CGCAAACUCUGAAUCAACAtt-3= (Invitrogen); siRNA against MFN2 was 5=-GACUAUAAGCUGCGAAUUAtt-3= (Invitrogen); siRNA against OPA1 was 5=-GCUUUAUGACAGAACCGAAtt-3= (Invitrogen); siRNA against Drp was 5=-GGUUCAUCAGUAAUCCUAAtt-3= (Invitrogen); and siRNA against Fis1 was 5=-GGAAUACGAGAAGGCCUUAtt-3= (Invitrogen).
Statistics. Data are shown as averages (ϮSD) taken from at least three independent experiments. Student's t-test was used for comparison of two data sets. Significance was defined as P Ͻ 0.05. Statistical software used was Excel (Microsoft).
RESULTS

Mitochondria in bronchial epithelial cells are fragmented in COPD lung tissues.
To characterize the mitochondrial morphology in bronchial epithelial cells in COPD lung tissues, we examined mitochondria in surgically resected lung tissues by using electron microscopy. Mitochondria in bronchiolar epithelial cells were prone to be swollen and more fragmented in COPD compared with those in controls (smokers without COPD) (Fig. 1A) . The major axes of more than 100 mitochondria were measured in each case, and average sizes were listed in Table 1 . Mitochondria in COPD tended to be shorter in average size of major axis than that of control cases (Table 1) .
CSE increases mitochondrial fragmentation in HBEC. To evaluate morphological changes of mitochondria in response to CSE exposure, we performed immunofluorescence staining with anti-TOM 20 to determine the mitochondrial outer membrane in HBEC. According to the staining pattern, the morphology of mitochondria was classified into three groups (elongated, fragmented, and others; Fig. 1B ), as described in MATERIALS AND METHODS. CSE clearly induced mitochondrial fragmentation (Fig. 1C, top) . We observed no significant increase in cell death (necrosis and apoptosis) after CSE exposure, which was examined by means of trypan blue staining and DNA fragmentation assays (data not shown). Quantification analysis of the mitochondrial morphology shows that CSE exposure increased the percentage of cells with fragmented mitochondria after 48 h (Fig. 1D ). CSE treatment also attenuated mitochondrial membrane potential compared with nontreated cells, which was determined by MitoTracker Red staining (Fig. 1C , middle), suggesting that the CSE-induced fragmented mitochondria may be dysfunctional.
Mitochondrial ROS production is involved in CSE-induced HBEC senescence.
Our previous study has demonstrated that CSE accelerated cellular senescence (15, 19) , which was at least partly mediated through protein oxidation (19) . Although CSE contains a wide array of toxic components, including ROS, the precise source of ROS involved in progression of cellular senescence in response to CSE exposure remains to be clearly elucidated. Mitochondria are a major source of intrinsic ROS production, and mitochondrial ROS is considered to be associated with aging (24, 44, 52) . Accordingly, we hypothesized that mitochondrial ROS production participates in the regulation of CSE-induced cellular senescence. First, we examined the effect of CSE on total intracellular and mitochondrial ROS production. A DCFDA assay showed an increase in total intracellular ROS production in response to CSE ( Fig. 2A) , and MitoSOX Red staining demonstrated that CSE increased mitochondrial-specific ROS production (Fig. 2, B and C) . NAC (an efficient antioxidant for intracellular ROS) and Mito-TEMPO (a specific antioxidant for mitochondrial ROS) inhib- ited the increase of mitochondrial ROS production by CSE (Fig. 2, B and C) . Interestingly, total intracellular ROS were also decreased in the presence of not only NAC but also Mito-TEMPO ( Fig. 2A) . Furthermore, both antioxidants also suppressed CSE-induced HBEC senescence shown by SA-␤-gal staining and p21 expression (Fig. 2, D and E) . Mitochondrial fragmentation increases mitochondrial ROS production and HBEC senescence. Next, we investigated the role of mitochondrial fragmentation in ROS production and in cellular senescence. Mitochondrial fragmentation was induced by knockdown of fusion proteins, OPA1 or MFNs (MFN1, MFN2). MFN1 and -2 share high amino acid identity and appear to function coordinately to regulate mitochondrial fusion (29) . Thus, to evaluate the role of MFNs, simultaneous knockdown of MFN1 and -2 was performed. Knockdown of OPA1 and MFNs apparently induced mitochondrial fragmentation, which was shown by immunofluorescence detection of TOM20 staining (Fig. 3A) . Intriguingly, attenuation of mitochondrial membrane potential accompanied by increased ROS production was also observed by knockdown of either protein (Fig. 3, A and B) . Knockdown of OPA1 and MFNs also induced HBEC senescence as measured by SA-␤-gal positive staining and p21 expression (Fig. 3, C and D) . This senescence was significantly inhibited by concomitant treatment with NAC and Mito-TEMPO. In contrast, mitochondrial fusion induced by knockdown of fission proteins (Fis1, Drp1) demonstrated no increase in HBEC senescence (Fig. 3E) .
ROS increases mitochondrial fragmentation in HBEC. Although our findings indicate that increased mitochondrial ROS production is at least partly attributed to mitochondrial fragmentation, prior studies have demonstrated that extrinsic ROS can cause mitochondrial fragmentation (13, 38, 45) . Furthermore, ROS within CSE has been proposed as the representative mechanism for toxicity (49) . Hence, we examined the involvement of ROS in mitochondrial fragmentation in the setting of CSE exposure. CSE-induced mitochondrial fragmentation was clearly inhibited by the presence of NAC (Fig. 4A) , indicating that ROS from CSE play a role in mitochondrial fragmentation. Fig. 2 . Involvement of mitochondrial reactive oxygen species (ROS) production in CSE-induced HBEC senescence. A: flow cytometric analysis of CM-H 2 DCFDA staining for intracellular ROS production in response to CSE exposure in the absence or presence of indicated antioxidants. N-acetylcysteine (NAC, 1 mM) and Mito-TEMPO (100 M) were pretreated for 3 h at 37°C before CSE exposure (1%, 1 h). The fluorescence level in the control treated cells was designated as a 100%. *P Ͻ 0.05. B and C: Mito SOX Red staining for mitochondrial ROS production. Fluorescence microscopic detection (B) and flow cytometric analysis (C) were performed. HBECs were cultured in the absence or presence of CSE (1%) for 1 h and stained with MitoSOX Red. NAC (1 mM) and Mito-TEMPO (100 M) were pretreated for 3 h at 37°C before CSE exposure. The fluorescence level in the control treated cells was designated as 100% in flow cytometric analysis. Shown is the average (ϮSD) from 3 independent experiments. *P Ͻ 0.05. D: HBEC senescence induced by CSE exposure in the absence or presence of antioxidants was evaluated by senescence-associated ␤-galactosidase (SA-␤-gal) staining. Shown is the percentage (ϮSD) of SA-␤-gal-positive cells from 3 independent experiments. *P Ͻ 0.05. E: Western blotting of p21 of cell lysates from control or CSE (1%) for 48 h-treated HBEC. NAC (1 mM) and Mito-TEMPO (100 M) were pretreated 3 h before CSE exposure. Top: the average (ϮSD) of relative increase in p21 normalized to ␤-actin, which is taken from densitometric analysis of Western blot from 3 independent experiments. *P Ͻ 0.05.
Mito-TEMPO partially inhibited CSE-induced mitochondrial fragmentation, suggesting that ROS derived from mitochondria at least partly contributes to CSE-induced mitochondrial fragmentation (Fig. 4B) . To further confirm the regulatory participation of ROS in mitochondria dynamics, we examined the effects of H 2 O 2 on mitochondrial morphology in HBEC. H 2 O 2 induced mitochondrial fragmentation, which was partially reversed by the presence of NAC (Fig. 4, B and C) . In addition, NAC also inhibited H 2 O 2 -induced cellular senescence (data not shown).
Drp1 and Fis1 were recruited to mitochondria by ROS exposure. Mitochondrial dynamics are orchestrated by the balance of expression levels between mitochondrial fission and fusion proteins (54) . To clarify the molecular mechanism of mitochondria fragmentation in response to CSE exposure, we isolated the mitochondrial fraction and examined the changes in expression levels of fusion proteins (MFN1, MFN2, OPA1) and fission proteins (Fis1, Drp1) in the mitochondrial fraction and total cell lysate, respectively. SDHA and HSP90 were mainly detected in the mitochondrial fraction and cytosolic fraction, respectively, indicating the efficient isolation of mitochondria (Fig. 5A) . Although no significant changes in protein levels were observed in total cell lysates, significant increase of Drp1 and Fis1 was observed in the mitochondrial fractions (Fig. 5B) . Furthermore, consistent with suppression of mitochondrial fragmentation, NAC inhibited the CSE-induced increase in Drp1 in the mitochondrial fraction (Fig. 5C) , suggesting the involvement of ROS in CSE-induced Drp1 translocation. To further elucidate the involvement of Drp1 translocation to the mitochondrion in the mechanism of CSEinduced mitochondrial fragmentation, Drp1 siRNA experiments were performed. Drp1 knockdown clearly inhibited CSE-induced mitochondrial fragmentation, suggesting the potential participation of Drp1 in CSE-induced mitochondrial fragmentation (Fig. 5D) . To clarify that Drp1-mediated mitochondrial fragmentation is a crucial step for mitochondrial ROS production, we examined MitoSOX staining in Drp1 siRNA-transfected HBEC. Drp1 knockdown clearly reduced MitoSOX staining in response to CSE exposure (Fig. 5E) . Taken together, CSE-induced Drp1 translocation to the mitochondrial fraction is involved in mitochondrial fragmentation, which is responsible for mitochondrial ROS production.
DISCUSSION
Recent advances in mitochondrial biology have shown the pivotal involvement of mitochondrial dynamics in a wide array of physiological and pathological processes (10, 29, 30, 41, 43) . However, a role for mitochondrial dynamics in lung disease pathogenesis has not been intensively investigated. Here, we initially illustrate the participation of mitochondrial dynamics in lung disease pathogenesis in terms of the regulation of HBEC senescence. Only a limited proportion of smokers develop clinical COPD, which may be attributed to the balance between the toxicity of CS exposure and host defensive mechanisms, suggesting that simple smoking exposure is not sufficient for COPD development. Thus, to clarify the clinically relevant causal link between mitochondrial dynamics and COPD development, we compared mitochondrial morphology in lung tissues from smokers without COPD and from COPD patients. In electron microscopic examination of lung tissues, we demonstrated that mitochondria in bronchial epithelial cells tended to be fragmented in COPD but not in smokers without COPD, suggesting the fission process dominancy of mitochondrial dynamics in COPD pathogenesis. These results are in accordance with previous reports demonstrating that mitochondria in skeletal muscles from COPD patients tended to be smaller in size accompanied by increased ROS production (16, 37, 39) .
Mitochondria fuse and divide with a purpose. In steady-state conditions, continuous changes of their shape through frequent fusion and fission are necessary for the maintenance of functional mitochondria with intact respiratory activity (54) . Mitochondrial fusion rescues physiological stress by allowing functional mitochondria to complement dysfunctional mitochondria by diffusion and sharing of components between organelles (53, 55), and mitochondrial fission helps not only the appropriate distribution of mitochondria according to the local energy demand but also helps the removal of damaged mitochondria through mitochondrial-specific autophagic degradation (mitophagy) (33, 34, 53 ). In the setting of disruption of mitochon- drial dynamics by excessive stress conditions, mitochondrial hyperfusion may be beneficial by increasing ATP production (stress-induced mitochondrial hyperfusion) (46) , whereas excessive mitochondrial fragmentation appears to be potentially harmful for cells (9) . Indeed, unbalanced mitochondrial fragmentation has been demonstrated to increase in dysfunctional mitochondria with excessive ROS and cytochrome c release, resulting in cellular dysfunction (9, 43) . Consistently, we observed that both accumulation of fragmented mitochondria during CSE treatment and knockdown of fusion proteins are associated with increased ROS production and cellular senescence in HBEC (Figs. 1, 2, and 3) . However, previous studies demonstrated that excessive mitochondrial fragmentation facilitates apoptosis (55) and elongation promotes senescence (26) , possibly through the balance between cytochrome c release and ROS generation in HeLa cells. We speculate our findings of mitochondrial fragmentation-mediated cellular senescence can be attributed to the cell type-specific apoptosis resistance of HBEC. Indeed, compared with alveolar epithelial cells, HBEC have been demonstrated to be apoptosis resistant (7).
Fragmented damaged mitochondria are generally destined to be eliminated by mitophagy (14, 33) ; therefore, it is not surprising to speculate that not only the disruption of mitochondrial dynamics but also impairment of mitochondrial degradation by mitophagy are both responsible for accumulation of fragmented mitochondria. We have recently reported insufficient autophagic degradation during CSE-induced HBEC senescence (15) , and now our recent findings also suggest there is insufficient mitophagy in the setting of CSE exposure (Ito, unpublished observations) .
Mitochondrial dynamics are regulated by the balance of expression levels between mitochondrial fission (Fis1 and Drp1) and fusion (MFN1, MFN2, and OPA1) proteins (6, 34) . CSE increased expression levels of Drp1 and Fis1 only in the mitochondrial fraction, suggesting that translocation of Drp1 and Fis1 to the mitochondrial fraction is involved in the mechanism of CSEinduced mitochondrial fragmentation. Posttranslational modification of Drp1 is a prerequisite for translocation to mitochondria, which is a fundamental process during mitochondrial fragmentation (4). Actually, translocation of Drp1 to the mitochondria is a proposed mechanism for ROS-induced mito- Western blotting using anti-SDHA and anti-HSP90 antibody on isolated mitochondria and cytosolic fractions. B: Western blot using anti-MFN1, ant-MFN2, anti-OPA1, anti-Drp1, anti-Fis1, anti-␤-actin, and anti-SDHA on cell lysates from control and CSE (1.0%)-treated HBEC. After 48 h treatment, mitochondria fractions and total cell lysates were collected. Right, the average (ϮSD) taken from 3 independent experiments shown as relative expression of CSE-treated compared with control treated. *P Ͻ 0.05. C: Western blot using anti-Drp1 and anti-SDHA of mitochondrial fractions from control and CSE (1.0%)-treated HBEC. HBEC were pretreated with NAC (1 mM) for 3 h followed by CSE (1.0%) exposure for 48 h. D: images of immunofluorescence staining of mitochondria of HBEC with anti-TOM 20 antibody (original magnification, ϫ1,000). HBEC were transfected with control siRNA (top) or Drp1 siRNA (bottom), incubated for 48 h followed by CSE (1.0%) exposure for 48 h, and stained. E: images of MitoSOX staining of HBEC. HBEC were transfected with control siRNA (top) or Drp1 siRNA (bottom) followed by CSE (1.0%) exposure.
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chondrial fragmentation in the model of Parkinson's disease, an age-related neurodegenerative disorder (45) . Hence, it is plausible that ROS in the CSE is responsible for modification of Drp1, resulting in activation and translocation to the mitochondria. Efficient inhibition of Drp1 translocation (Fig. 5C ) and mitochondrial fragmentation by NAC (Fig. 4A ) may further support this notion. Drp1 knockdown experiments elucidated that Drp1 translocation to the mitochondrial fraction is a crucial step for both mitochondrial fragmentation and mitochondrial ROS production in response to CSE exposure (Fig.  5 ). In accordance with our results, a recent paper demonstrated that Drp1 knockdown inhibited mitochondrial fragmentation and subsequent mitochondrial ROS production by high-glucose stress in endothelial cells (43) . Fis1 is a mitochondrial outer-membrane-associated protein known to have important roles in mitochondrial fragmentation (6). Although we speculate that Fis1 is also involved in the regulation of CSE-induced mitochondrial fragmentation, detailed mechanisms for activation and recruitment of Fis1 have not been described. Therefore, further studies are needed to elucidate more detailed mechanisms of CSE-induced mitochondrial fragmentation.
Although ROS are biologically important products of mitochondria, acting as signal transduction molecules, excessive ROS are harmful via oxidative modifications of cellular components, resulting in cellular senescence accompanied by accumulations of DNA damage, oxidized proteins, and lipid peroxidation of lipofuscin (20, 23, 31, 36) . Recently, Skulachev et al. reported that mitochondrial ROS are especially important for progression of an aging phenotype, which was shown using the mitochondrial targeted antioxidant SkQ1 (24, 44) . In support of this notion, Mito-TEMPO efficiently suppressed CSE-induced HBEC senescence, suggesting that ROS in CSE is mainly involved in the initial step of mitochondrial fragmentation and that subsequent ROS release from fragmented mitochondria is the more crucial mechanism for CSEinduced HBEC senescence.
To better understand the mechanism of ROS release from fragmented mitochondria, we examined the possible involvement of mitochondrial transition pore (MTP) opening using cyclosporine A (CyA), an inhibitor of pore opening (27) . However, no inhibitory effect of CyA was observed on ROS release (data not shown), indicating that MTP opening is not involved in CSE-induced ROS release from fragmented mitochondria. To clarify the causal link between mitochondrial fragmentation and ROS release in response to CSE exposure, future studies need to address other possible mechanisms for ROS release, including dysfunction of respiratory chain complexes (28) .
There are several limitations for interpreting our experimental results. Because of our methodological limitations, electron microscopic examination was performed by two-dimensional means. Therefore, our interpretation of mitochondrial fragmentation in HBEC from COPD patients may not be entirely representative of the morphological pattern of complex threedimensional structures of mitochondria. Also, although mitochondrial fragmentation plays an important regulatory role in CSE-induced mitochondrial ROS release, it is likely that there are other mechanisms for mitochondrial ROS production without excessive fragmentation. Finally, because our results were mainly based on in vitro experimental models using short-term CSE exposure, future studies need to be performed using appropriate animal models for COPD development with modulating mitochondrial dynamics.
In summary, mitochondria in bronchial epithelial cells were prone to be fragmented in COPD lung tissues. ROS in CSE is involved in the initiation of mitochondrial fragmentation, whereas further increase in ROS production from fragmented mitochondria is mainly responsible for acceleration of cellular senescence in HBEC. Therefore, appropriate control of mitochondria dynamics or mitochondria-targeted antioxidants may ameliorate CS-induced acceleration of cellular senescence. Taken together, mitochondrial dynamics likely play an important regulatory role in CSE-induced cellular senescence in HBEC, which is a promising clue for understanding the pathogenesis of the senescence-associated lung disease COPD.
